Telix Pharmaceuticals TLX
NASDAQ TLX
$9.23 +0.20 (+2.27%)
As of: Oct 28, 2026 · 10:03 AM EDT

Telix Pharmaceuticals (TLX) Enterprise Value (2024 - 2026)

Updated

Telix Pharmaceuticals' Enterprise Value was $3.61 billion in the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Enterprise Value (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Telix Pharmaceuticals' Enterprise Value was $2.85 billion through Jun 30, 2026; for the year ended Dec 31, 2025, it was $2.36 billion, down 49.3% from the prior year.

  • In earlier years, Enterprise Value was $4.65 billion in the year ended Dec 31, 2024.
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Enterprise Value since the quarter ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,206.37 Bn 1,174.95 Bn 19.71 Bn
2 Johnson & Johnson 647.04 Bn 566.90 Bn 17.30 Bn
3 AbbVie 506.16 Bn 479.31 Bn 12.70 Bn
4 Merck 349.94 Bn 304.37 Bn 12.21 Bn
5 Novartis Ag 299.20 Bn 272.77 Bn -
6 Astrazeneca 263.53 Bn 237.29 Bn 12.86 Bn
7 Amgen 242.16 Bn 197.56 Bn 7.24 Bn
8 Gilead Sciences 197.76 Bn 171.96 Bn 6.22 Bn
9 Pfizer 169.85 Bn 116.80 Bn 10.94 Bn
10 Telix Pharmaceuticals 3.06 Bn 2.02 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.61 Bn
Dec 31, 2025 2.36 Bn
Dec 31, 2024 4.68 Bn
API Access

Telix Pharmaceuticals Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=TLX&period=max&api_key=YOUR_API_KEY